Trinity Biotech (TRIB) Net Cash Flow (2016 - 2024)
Historic Net Cash Flow for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to $2.7 million.
- Trinity Biotech's Net Cash Flow rose 21299.53% to $2.7 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$1.3 million, marking a year-over-year increase of 8681.33%. This contributed to the annual value of $1.7 million for FY2024, which is 15807.25% up from last year.
- According to the latest figures from Q4 2024, Trinity Biotech's Net Cash Flow is $2.7 million, which was up 21299.53% from -$3.9 million recorded in Q2 2024.
- In the past 5 years, Trinity Biotech's Net Cash Flow ranged from a high of $14.8 million in Q4 2020 and a low of -$7.1 million during Q2 2023
- Moreover, its 5-year median value for Net Cash Flow was -$3317.0 (2024), whereas its average is $610372.0.
- As far as peak fluctuations go, Trinity Biotech's Net Cash Flow soared by 52308.98% in 2020, and later crashed by 39571871.18% in 2023.
- Trinity Biotech's Net Cash Flow (Quarter) stood at $14.8 million in 2020, then tumbled by 114.5% to -$2.2 million in 2021, then skyrocketed by 67.66% to -$696000.0 in 2022, then plummeted by 237.21% to -$2.3 million in 2023, then skyrocketed by 213.0% to $2.7 million in 2024.
- Its last three reported values are $2.7 million in Q4 2024, -$3.9 million for Q2 2024, and -$3317.0 during Q1 2024.